Abyrx has entered into a distribution deal with SurgiCor to help bring its hemostatic bone putty products to orthopedic and spinal surgeons across the U.S. The deal covers Abyrx's Hemasorb, Hemasorb Plus, Hemasorb Apply and AHBP.
Z-Medica, which has developed the QuikClot line of devices used to treat heavy bleeding, has set up a facility in Boston. The expansion gives the Wallingford, Conn.-based company closer access to research and development efforts in Massachusetts that focus on finding new ways to control bleeding, President and CEO Larry Hicks said.
AngioDynamics has received investigational device exemption approval from the FDA to conduct a clinical study of its NanoKnife technology, which uses precise ablation to treat patients with localized prostate cancer. The trial will enroll 200 patients from six clinical sites in Europe.
OASIS Medical and Shape Ophthalmics have announced a joint venture to develop and market a shape memory plug that can be used to treat dry eye. The plug, which works using natural body heat, will be manufactured by OASIS and could be available starting next year.
Vertos Medical has secured $23 million in a Series E funding round led by Pitango Venture Capital. The California-based spinal device company has FDA clearance for a "mild" outpatient procedure intended to enable patients with lumbar spinal stenosis to walk with less pain and stand longer.